Konstantin H. Dragnev, Mustafa Erman, Emilio Bria, Jay M. Lee, Cole Manschot, Jeffrey Thompson, Ayman Samkari, Jonathan Spicer. "KEYMAKER-U01E: A phase 2 umbrella study with rolling arms of investigational agents with or without chemotherapy plus pembrolizumab for resectable stage II–IIIB (N2) non–small-cell lung cancer (NSCLC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps8115